Policy amendment allows practitioners to request access to psychedelic drugs for patients with serious or life-threatening conditions on a case-by-case basis VANCOUVER, BC, Dec. 22, 2021 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI), a leader in psychedelics-focused mental healthcare, commends Health Canada’s leadership for amending the Special Access Programme…


Previous articleOptimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Next articlePTSF90 – Colorado’s Natural Medicine Healing Act and Guidelines for Emergency Ketamine Administration